Determination of Effective Half-Life (Teff) of Radioactive 131I in Thyroid Cancer Patients

被引：0
|
作者：
Vu, H. T. [1 ]
Hrejsa, A. [2 ]
Markovic, A. [2 ]
机构：
[1] Rosalind Franklin Univ Med & Sci, N Chicago, IL USA
[2] Advocate Lutheran Gen Hosp, Park Ridge, IL USA
来源：
AMERICAN JOURNAL OF ROENTGENOLOGY | 2007年 / 188卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] DETERMINATION OF THE HALF-LIFE OF RADIOACTIVE SUBSTANCES
    WEAVER, RE
    AMERICAN JOURNAL OF PHYSICS, 1952, 20 (03) : 192 - 192
  • [32] Relationship between estimated glomerular filtration rate and biological half-life of 131I Retrospective analysis in patients with differentiated thyroid carcinoma
    Vogel, K.
    Opfermann, T.
    Wiegand, S.
    Biermann, J.
    Busch, M.
    Winkens, T.
    Freesmeyer, M.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2013, 52 (05): : 164 - 169
  • [33] Effect of 131I on salivary glands function in 131I treated thyroid cancer patients
    Yuan, Z.B.
    Jin, C.Q.
    Yu, Y.L.
    Zhu, R.S.
    He Jishu/Nuclear Techniques, 2001, 24 (05):
  • [34] UPTAKE OF 131I IN HOUSEHOLDS OF THYROID CANCER PATIENTS
    North, David L.
    HEALTH PHYSICS, 2013, 104 (04): : 434 - 436
  • [35] EFFECTIVE HALF-LIFE OF I-131 IN THYROID CARCINOMA PATIENTS RECEIVING LOW-DOSE ABLATION THERAPY WITH RTSH
    Willowson, K.
    Bailey, D.
    Forwood, N.
    Bailey, E.
    Roach, P.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 35 - 35
  • [36] Qualitative and Quantitative Impact of Protective Glucocorticoid Therapy on the Effective 131I Half-Life in Radioiodine Therapy for Graves Disease
    Hautzel, Hubertus
    Pisar, Elisabeth
    Yazdan-Doust, Nahid
    Schott, Matthias
    Beu, Markus
    Mueller, Hans-Wilhelm
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (12) : 1917 - 1922
  • [37] RADIOACTIVE HALF-LIFE DETERMINATION WITH AN ISOTOPE GENERATOR
    OOTUKULA.JM
    RAMASWAM.MK
    AMERICAN JOURNAL OF PHYSICS, 1971, 39 (02) : 221 - &
  • [38] Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of 131I during radioiodine therapy of Graves’ disease
    C. Happel
    W. T. Kranert
    D. Gröner
    J. Baumgarten
    J. Halstenberg
    B. Bockisch
    A. Sabet
    F. Grünwald
    Endocrine, 2021, 73 : 125 - 130
  • [39] Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of 131I during radioiodine therapy of Graves' disease
    Happel, C.
    Kranert, W. T.
    Groener, D.
    Baumgarten, J.
    Halstenberg, J.
    Bockisch, B.
    Sabet, A.
    Gruenwald, F.
    ENDOCRINE, 2021, 73 (01) : 125 - 130
  • [40] Whole-Body Radioiodine Effective Half-Life in Patients with Differentiated Thyroid Cancer
    Klain, Michele
    Nappi, Carmela
    De Risi, Marina
    Piscopo, Leandra
    Volpe, Fabio
    Manganelli, Mariarosaria
    Caiazzo, Elisa
    Bianco, Davide
    Schlumberger, Martin
    Cuocolo, Alberto
    DIAGNOSTICS, 2021, 11 (10)
12345